NanoCarrier Co., Ltd.
TSE:4571.T
Overview | Financials
Company Name | NanoCarrier Co., Ltd. |
Symbol | 4571.T |
Currency | JPY |
Price | 167 |
Market Cap | 11,792,549,857 |
Dividend Yield | 0% |
52-week-range | 135 - 259 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Shiro Akinaga Ph.D. |
Website | https://www.nanocarrier.co.jp |
An error occurred while fetching data.
About NanoCarrier Co., Ltd.
NanoCarrier Co., Ltd. researches, develops, produces, and sells pharmaceuticals using micelle nanoparticle technology primarily for the treatment of cancer in Japan. The company's product pipeline includes VB-111 non-proliferative adenovirus vector, which is in phase III clinical trials for the treatment of ovarian cancer, as well as in phase II clinical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD